Summary & Overview
HCPCS G9428: Pathology Report for Invasive Tumor Histologic Features
HCPCS Level II code G9428 denotes a detailed pathology report for invasive tumors that documents patient category, tumor thickness, ulceration, mitotic rate, peripheral and deep margin status, and microsatellitosis. These elements are critical for staging, prognosis, and downstream treatment planning for malignant skin and soft-tissue lesions. Nationally, standardized reporting of these features supports consistent clinical decision-making and aligns pathology documentation with oncology and surgical care pathways. Key payers in this review include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context and common sites of service tied to G9428, a summary of how major payers commonly categorize and reimburse pathology reporting services, and benchmarks for typical utilization patterns where available. The publication also highlights documentation components tied to G9428 to help organizations align pathology reports with payer expectations and clinical staging needs. Data not available in the input is noted where payer-specific rate tables, ICD-10 pairings, or associated taxonomies would normally appear.
Billing Code Overview
HCPCS Level II code G9428 describes a pathology report for invasive tumors that includes the patient category, tumor thickness, presence of ulceration and mitotic rate, peripheral and deep margin status, and presence or absence of microsatellitosis. This reporting item is specific to surgical pathology evaluation of invasive cutaneous or soft-tissue tumors where those histopathologic features are essential for prognostic assessment and staging.
-
Service type: Pathology surgical specimen evaluation and detailed histopathology reporting
-
Typical site of service: Hospital pathology laboratory, independent pathology laboratory, or outpatient surgical pathology service
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient presents to dermatology with a suspicious pigmented lesion on the upper back. The lesion is surgically excised by a dermatologic surgeon in an outpatient ambulatory surgery center. The specimen is submitted to pathology with clinical history indicating concern for invasive cutaneous melanoma. The anatomic pathology report documents tumor staging details required for melanoma management: pathological tumor category (pT), tumor thickness (Breslow depth), presence or absence of ulceration, mitotic rate (per mm2), status of peripheral and deep margins, and presence or absence of microsatellitosis. This detailed pathology documentation supports staging, prognosis, multidisciplinary treatment planning (including consideration of sentinel lymph node biopsy and adjuvant therapy), and accurate coding and billing for the pathology service. Typical site of service: outpatient surgery center or hospital outpatient department; service type: surgical pathology report for skin excision with melanoma evaluation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the pathology interpretation requires substantially greater work or complexity than usual (e.g., unusually complex immunohistochemical panel or extended consultative effort). |
23 |